D-dimer concentration is associated with increased risk for VTE and greater absolute benefit of extended prophylaxis with betrixaban in acutely Ill medical patients: insights from the APEX trial
27 August 2017 (08:30 - 12:30)
Organised by:
Abstract
Slides
About the speaker
Hospital of the University of Pennsylvania, Philadelphia (United States of America)
14 More presentations in this session
Access the full session
The Event
ESC Congress 2017
27 August 2017
08:30 CET
You may be interested in
Congress Presentation
18 March 2022
Congress Presentation
Congress Presentation
